Joseph S. D’Arrigo, Ph.D.

Dr. D’Arrigo is Dir. of R&D, and C.E.O., of CCT Pharma Inc. (a division of Cav-Con Inc.). His research and business activities are concerned with the continued development of the medical (therapeutic and diagnostic) applications of CCT Pharma’s originally patented, and subsequently refined/confidentiality-safeguarded, LCM technology both in the U.S.A. and overseas. Dr. D’Arrigo received a B.A. in Chemistry in 1967 from Queens College, CUNY, in New York City. He attended the University of Wisconsin Medical School in Madison for two years, passed Part I of the National Medical Boards in 1969, and then received a Ph.D. degree in Neuroscience in 1972 (specializing in membrane biophysics) at the Brain Research Institute, University of California at Los Angeles (UCLA). Following an N.I.H. postdoctoral fellowship, to conduct research in membrane biophysics and surface chemistry, at the University of Utah College of Medicine (1972-73), he held faculty positions at the University of Utah in Salt Lake City (1973-75) and the University of Hawaii School of Medicine in Honolulu (1975-84), as well as a visiting fellow position to conduct research in colloid and interfacial chemistry at the Institute of Advanced Studies, Australian National University (Canberra, 1982-83). Thereafter, Dr. D’Arrigo entered industry as a research manager at AMF Inc., Analytical Chemistry Division, in Connecticut (1985). He took over full-time as Director of R&D, and C.E.O., of Cav-Con Inc. (in Farmington, Conn.) starting in 1986. Dr. D’Arrigo has written or co-written 45 research articles, authored three books, and has been granted 9 patents (in 8 countries). He has consulted for numerous corporations on medical and industrial applications of LCM technology, and served as principal investigator on various N.I.H. SBIR Phase I (1987 & 1993) and Phase II (1989-91) maximum-level grants to Cav-Con Inc. for continued development of the LCM technology.

PUBLICATIONS:

Patents: (-- "prior art" now also in "public domain"),

1. D’Arrigo, J.S. “Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures”. United States Patent No. 4,684,479 (issued August 4, 1987). [Abstract] [Full Text]

2. ibid. (2nd edition, revised), Canada Patent No. 1,267,055 (issued March 27, 1990). [Abstract] [Full Text]

3. ibid. (3rd edition, revised), Japan Patent No. 1,815,442 (issued January 18, 1994). [Abstract] [Full Text]

4. D’Arrigo, J.S. “Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles”. United States Patent No. 5,215,680 (issued June 1, 1993). [Abstract] [Full Text]

5. ibid. (2nd edition, revised), Australia Patent No. 657480 (issued July 24, 1995). [Abstract] [Full Text]

6. ibid. (3rd edition, revised), European P.O. Patent No. 0467031 (granted July 30, 1997). [Abstract] [Full Text]

7. ibid. (3rd edition), United Kingdom Patent No. 0467031 (issued 1997). [Abstract] [Full Text]

8. ibid. (3rd edition), Germany Patent No. DE69127032T2 (issued February 26, 1998). [Abstract] [Full Text]

9. ibid. (3rd edition), France Patent No. 0467031 (issued 1997). [Abstract] [Full Text]

10. ibid. (3rd edition), Italy Patent No. 0467031 (issued 1997). [Abstract] [Full Text]

Books:

D’Arrigo, J.S. (1986). Stable Gas-in-Liquid Emulsions: Production in Natural Waters and Artificial Media, 220 pp.; Elsevier Science Publishers, Amsterdam and New York.

D'Arrigo, J.S. (2003). Stable Gas-in-Liquid Emulsions: Production in Natural Waters and Artificial Media, Second edition, 323 pp.; Elsevier Science Publishers, Amsterdam and New York.

D'Arrigo, J.S. (2011). Stable Nanoemulsions: Self-Assembly in Nature and Nanomedicine, 436 pp.; Elsevier, Amsterdam and Oxford.

Articles:

(Full listing available of 48 research papers in scientific journals)